Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering
ZUG, Switzerland, May 28, 2025--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 2.38 million shares at a price of CHF 97.75 per share for a total consideration of CHF 232.5 million in the context of the accelerated bookbuild offering ("ABO") of Galderma shares by Sunshine SwissCo GmbH ("EQT"), Abu Dhabi Investment Authority and Auba Investment Pte. Ltd. launched yesterday evening. The repurchase was made at the same price per share determined by the bookbuilding offering.
The repurchase, which is expected to settle on June 2, is being financed by Galderma's existing liquidity on hand and will not affect the company's ability to deliver on its strategic and financing priorities.
The shares will be held in treasury for future use in connection with Galderma's employee participation plans, business development opportunities and/or treasury management.
"The repurchase of shares announced today is a testament to the confidence of the Executive Committee and the Board of Directors in the performance fundamentals and the attractive shareholder value creation outlook of Galderma. The participation in the offering reflects our continued focus on disciplined capital allocation, commitment to attractive shareholder returns and our confidence in Galderma's strong cash generation and investment grade balance sheet."
FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER
GALDERMA
Following the closing of the ABO, the free float in Galderma's shares is expected to increase from 41.8% to 49.8%.
About GaldermaGalderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
Forward-looking statements
Certain statements in this announcement are forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", " believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. These forward-looking statements reflect, at the time, Galderma's beliefs, intentions and current targets/ aims concerning, among other things, Galderma's results of operations, financial condition, industry, liquidity, prospects, growth and strategies and are subject to change. The estimated financial information is based on management's current expectations and is subject to change. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results may differ from those set forth in the forward-looking statements as a result of various factors (including, but not limited to, future global economic conditions, changed market conditions, intense competition in the markets in which Galderma operates, costs of compliance with applicable laws, regulations and standards, diverse political, legal, economic and other conditions affecting Galderma's markets, and other factors beyond the control of Galderma). Neither Galderma nor any of their respective shareholders (as applicable), directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak of the date of this announcement. Statements contained in this announcement regarding past trends or events should not be taken as a representation that such trends or events will continue in the future. Some of the information presented herein is based on statements by third parties, and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, reasonableness, accuracy, completeness or correctness of this information or any other information or opinions contained herein, for any purpose whatsoever. Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527014109/en/
Contacts
For further information:
Christian Marcoux, M.Sc.Chief Communications Officerchristian.marcoux@galderma.com +41 76 315 26 50
Richard HarbinsonCorporate Communications Directorrichard.harbinson@galderma.com +41 76 210 60 62
Emil IvanovHead of Strategy, Investor Relations, and ESGemil.ivanov@galderma.com +41 21 642 78 12
Jessica CohenInvestor Relations and Strategy Directorjessica.cohen@galderma.com +41 21 642 76 43
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
11 minutes ago
- Business Wire
Bardavon Launches Online Physical Medicine Portal Benefiting Claims Adjusters and Nurse Case Managers
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Bardavon is proud to announce the launch of Link, a new digital portal designed specifically for Adjusters and Nurse Case Managers (NCMs). This platform brings clarity, efficiency, and actionable insight to the forefront of injury case management and physical rehabilitation. Link is a one-stop online destination that gives Adjusters and NCMs 24/7 access to the information they need, when they need it. Key features of Link include: At-a-glance case summaries including actual visit counts, estimated case duration, and authorized visits remaining Snapshot views of patient case status such as current risk level, no-shows, care gaps, and reauthorization needs Easy access to view and download all case notes, updated nightly and viewable in-line with the patient record Comprehensive case details including appointments, attendance, predictive analytics, and open items requiring action Quality oversight includes clinical team case interventions for treating therapist and alerts to stakeholders regarding case progression All information is refreshed nightly to ensure timely and accurate updates. With Link, Bardavon takes information that was previously provided to Adjusters and NCMs incrementally via e-mail or fax and now presents it in an easily digestible and meaningful manner to generate actionable insights. Link is built on the same platform that Bardavon's clinical oversight team uses every day, effectively providing Adjusters and NCMs the same 360 degree case management view as Bardavon's clinical oversight staff. 'We're excited to roll out the Link online portal as part of our commitment to building tools and workflow guides focused on supporting Adjusters and Nurse Case Managers, with the hope of supercharging their workflow,' said Jen Henry, VP of Clinical Operations and Services at Bardavon. 'Link empowers our partners to proactively manage cases, access critical insights, and take timely action to keep care on track. Most importantly, it allows them to manage cases on their time, with the certainty of complete and consolidated case information.' Why Link? The name reflects the portal's core purpose: linking stakeholders to timely, relevant information, in turn fostering stronger collaboration, better communication, and accelerated case progression. Over time, Link will evolve to include additional features such as one-click access to submit new referrals and re-authorizations, visibility to the status of new referrals, and more. Built on the same platform as Bardavon's clinical coaching portal, Link pulls from the same prioritized clinical and administrative data set, providing Adjusters and NCMs the information they need, accessible when they want it. Bardavon recognizes that every adjuster and case manager works differently—which is why Link will never be mandatory. We pride ourselves on listening to our clients and making sure communication and reporting preferences can be tailored at the individual user level, whether that means using Link or continuing to receive notes and case-level details via email or fax. And just like other Bardavon program enhancements, such as Recovery+, there is no charge or fee associated with Link. "Ultimately, we see the release of Link as a natural extension of our commitment to developing tools that make the jobs of Nurse Case Managers and Adjusters easier, better, and more straight-forward,' said Sarah Meyer, Chief Operating Officer at Bardavon. 'Our focus is on meeting each end user where they are—adapting to their preferred workflow and timing, so they can work in the way that suits them best." To learn more about the Link portal, visit Bardavon is a nationwide network of PT/OT providers treating workplace injuries while focusing on the unique needs of each injured worker and their return-to-work goals. Our high-touch, tech-enabled service enhances and simplifies the patient management experience for each stakeholder, including payers, adjusters, case managers, and injured workers. This optimizes claims outcomes and reduces costs. To learn more, visit
Business Wire
11 minutes ago
- Business Wire
G42 Launches OpenAI GPT-OSS Globally on Core42's AI Cloud
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)-- Core42, a G42 company specializing in sovereign cloud and AI infrastructure, announced the availability of OpenAI's latest open-weight AI models, including gpt-oss-20B and gpt-oss-120B, on the Core42 AI Cloud platform, instantly accessible through the Core42 Compass API. The deployment enables enterprises, researchers, and developers to run the models on a choice of leading silicon platforms with sovereign, scalable, and high-performance capabilities. Integrated into Compass API with the flexibility to access a wide spectrum of high-performance compute platforms, Core42 delivers industry-leading inference speeds of up to 3,000 tokens per second per user, enabling real-time AI at global scale while aligning workloads with the optimal infrastructure for price-performance and scalability. This deployment delivers tailored performance for low-latency inference workloads and applications, reinforcing Core42's commitment to secure and optimized global sovereign-enabled AI infrastructure. 'Core42 AI Cloud, powered by silicon-diverse infrastructure, delivers the flexibility and performance needed for today's AI workloads,' said Kiril Evtimov, CEO of Core42 and Group CTO, G42. 'Through the Compass API, organizations can access the latest open-weight AI models and choose the optimal platform to scale transformation, optimize performance and cost, and drive progress across global markets.' Key Benefits of Core42's Open-Weight Deployment: Enterprise-scale performance – Run the fastest, most demanding workloads at global scale, enabling advanced automation, decision-making, and real-time AI experiences. Sovereign-ready scalability – Deploy high-performance AI in-country with full sovereign controls, supporting secure operations in regulated sectors such as healthcare, finance, and national security. Optimized for committed environments – Deliver fast, scalable AI in-country with sovereign controls for organizations operating under committed infrastructure agreements, ensuring predictable cost and performance. Cost-efficient agentic AI – Run agentic workloads at the lowest possible cost while maintaining in-country deployment and sovereign controls, making advanced AI accessible to cost-sensitive use cases. Available now through Compass API, these models let organizations run and adapt AI locally or in the cloud, with full transparency, fine-tuning, and sovereign deployment options. Customers can align performance, cost, and compliance to their needs. This release marks a pivotal move toward enterprise AI autonomy. With open-weight access, businesses can shape AI to their unique needs and unlock new possibilities for innovation at scale. This announcement builds on G42's recent milestones, including the unveiling of a 5GW US-UAE AI campus and the launch of the 1GW Stargate UAE facility as Phase 1 of the project, as well as a $1.5 billion investment from Microsoft in 2024, reinforcing the UAE's role as a global AI hub. For more information, visit and About Core42 Core42, a G42 company, empowers individuals, enterprises, and nations to unlock the full potential of AI through its comprehensive enablement capabilities. As a leading provider of sovereign cloud, AI infrastructure, and services, our mission is to accelerate the achievements of others and help them reach their most ambitious goals. To learn more, please visit and follow Core42 LinkedIn, Core42 Instagram, Core42 X About G42 G42 is a global leader in creating visionary artificial intelligence capabilities for a better tomorrow. Born in Abu Dhabi and operating around the world, G42 champions AI as a powerful force for good. Its people are constantly reimagining what technology can do, applying advanced thinking and innovation to accelerate progress and tackle society's most pressing problems. G42 is joining forces with nations, corporations and individuals to create the infrastructure for tomorrow's world. From molecular biology to space exploration and everything in between, G42 realizes exponential possibilities, today. For further information visit Source: AETOSWire
Business Wire
11 minutes ago
- Business Wire
Aviation Capital Group Announces Record Second Quarter 2025 Financial Results
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aviation Capital Group LLC ('ACG'), a premier global full-service aircraft asset manager, released its financial results for the second quarter of 2025. ACG's financial statements and investor presentation for the second quarter of 2025 are available on its website at 'ACG continued to deliver solid performance with record earnings in the first half of 2025 driven by robust operating lease revenue, profitable aircraft sales, and sizeable settlements on insurance claims related to our Russia exposure. We are in growth mode with $9.5 billion of aircraft commitments through 2031 combined with industry leading low leverage of 1.9x. We continue to optimize our business and fine-tune our strategy to take advantage of opportunities in this market,' said Tom Baker, Chief Executive Officer and President of ACG. Financial Results Total revenues of $612.5 million for the six months ended June 30, 2025, an increase of 4% over the same period last year Total pre-tax net income of $613.8 million for the six months ended June 30, 2025, including $506.4 million of insurance settlement proceeds Total pre-tax net income, excluding insurance proceeds, of $107.4 million for the six months ended June 30, 2025, an increase of 105% over the same period last year Recognized a net benefit of $506.4 million from the settlement of insurance claims related to our losses incurred from Russia exposure during the second quarter of 2025. An additional $38.4 million of insurance settlement proceeds will be recognized in the third quarter of 2025 Available liquidity of $5.8 billion as of June 30, 2025, an increase of $1.3 billion over March 31, 2025, positioning us to fund maturing debt, aircraft purchases, and future growth Net debt to equity ratio of 1.9x as of June 30, 2025, a reduction from 2.3x as of March 31, 2025, and well below our long-term target leverage of 2.5x Cash flow from operations of $277.4 million for the six months ended June 30, 2025 Deployed $1.6 billion of capital expenditures on purchases of aircraft assets in the first six months of 2025, with 31 additional aircraft acquisitions and deliveries expected during the second half of 2025 Strong sales pipeline, with $893.9 million of aircraft held for sale as of June 30, 2025 Portfolio Highlights Added ten new technology aircraft during the second quarter, comprised of eight Airbus A320neo family aircraft, one Airbus A330neo family aircraft and one Boeing 737 MAX aircraft, from a combination of OEM deliveries, sale-leasebacks and the secondary market Completed acquisition of the first three aircraft of a portfolio purchase from Avolon Aerospace Leasing Limited during the second quarter, with the remainder scheduled to close in 2025 Sold eight aircraft and three airframes for a net gain of $21.7 million during the second quarter, taking advantage of a strong market for used aircraft Weighted average age of our owned portfolio was 5.7 years as of June 30, 2025, down from 5.9 years as of March 31, 2025 Weighted average remaining lease term was 6.9 years as of June 30, 2025 Financing Activity Closed a $1.0 billion secured delayed draw term loan with a syndicate of lenders that matures in June 2027 and remained undrawn at quarter-end Increased the available capacity under our unsecured revolving line of credit with Tokyo Century to $1.5 billion Maintained significant unencumbered asset to unsecured debt coverage of 1.5x as of June 30, 2025 Notes Regarding Financial Information Presented in This Press Release The financial information presented in this press release is not audited. We reference certain metrics in this press release, as well as net debt to equity, which is a non-GAAP number. Net debt is our total outstanding debt less our cash and cash equivalents. Equity is our total equity as determined in accordance with GAAP. We believe this measure may further assist investors in their understanding of our performance. This measure should not be viewed in isolation and should only be used in conjunction with and as a supplement to our U.S. GAAP financial measures. Non-GAAP measures and metrics are not uniformly defined by all companies, including those in our industry, and so this additional information may not be comparable with similarly titled measures and metrics and disclosures by other companies. Please refer to our Q2 2025 Investor Presentation located at for additional information regarding certain metrics included in this announcement and a reconciliation of net debt to equity, a non-GAAP measure, to its most directly comparable GAAP financial measure. Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable federal securities laws. Any such statements, other than statements of historical fact, are based upon our current expectations and assumptions concerning future events, which are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. Accordingly, such statements are not guarantees or assurances of any aspect of future performance. Except as required by applicable law, we do not undertake any obligation to, and will not, update any forward-looking statements, whether as a result of new information, future events or otherwise. About Aviation Capital Group Aviation Capital Group is one of the world's premier full-service aircraft asset managers with approximately 500 owned, managed and committed aircraft as of June 30, 2025, leased to roughly 90 airlines in approximately 50 countries. It specializes in commercial aircraft leasing and provides certain aircraft asset management services and aircraft financing solutions for third parties. It was founded in 1989 and is a wholly owned subsidiary of Tokyo Century Corporation. Follow ACG on LinkedIn, and for more information, visit
